AI & Optometry: Innovation at the Forefront of Care at Rose Optometry

At Rose Optometry, we’re always looking ahead. Innovation has always been at the heart of what we do - and in 2026, we’ll be taking a major step forward by bringing advanced, AI-powered health screening to our patients through Toku Eyes.

Their secure models are built on the largest, fastest-growing dataset of retinal images linked to medical records - over 4.3 million retinal images and counting - allowing us to deliver broader health insights from a simple eye exam.

Next-Generation Screening, Right in Our Office

• Biological Age (BioAge)
Using vascular and metabolic indicators in the retina, BioAge estimates your biological age, offering a clearer picture of your overall health than the calendar alone.

• Cardiovascular Risk (CLAiR)
Real-time, non-invasive cardiovascular risk scoring from a retinal photo. No lab tests. No extra appointments. Just instant insights that help keep you ahead of heart disease.

• Chronic Kidney Disease (MyKidneyAI)
For our patients with diabetes, MyKidneyAI can detect elevated kidney disease risk early, long before symptoms appear, using the same retinal images captured during routine eye exams.

‍

At Rose Optometry, we’re committed to staying at the forefront of eye and whole-body health.With AI-powered screening arriving in 2026, the future of care is clearer than ever, and we’re excited to bring it to you.